New hope for tiniest lungs: safer steroid tested on premature babies
NCT ID NCT06589245
Summary
This study is testing the safety of an inhaled steroid called ciclesonide in very premature babies who are at high risk for developing a serious lung condition called bronchopulmonary dysplasia (BPD). The researchers want to see if this medicine, which is already used for asthma in older children, is absorbed into the body and causes fewer side effects than other steroids used for preemies. They will enroll 30 babies to carefully monitor for problems like high blood sugar, poor growth, and high blood pressure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Mercy Kansas City
RECRUITINGKansas City, Missouri, 64108, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.